NASDAQ:CNTB

Connect Biopharma Holdings American Depositary Shares Stock Forecast

etoro logo Buy CNTB
*Your capital is at risk
$2.49
+0.370 (+17.45%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CNTB
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Volatile ride for Connect Biopharma Holdings Ltd American stock price on Monday moving between $2.05 and $2.56
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Nov 14, 2025 Gain 17.45%

The Connect Biopharma Holdings Ltd American stock price gained 17.45% on the last trading day (Monday, 17th Nov 2025), rising from $2.12 to $2.49. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 24.84% from a day low at $2.05 to a day high of $2.56. The price has risen in 6 of the last 10 days and is up by 50.91% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $5.59 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $1.95, a level that may pose a second chance to hit a runner. According to fan-theory $2.62 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

CNTB Signals & Forecast

The Connect Biopharma Holdings Ltd American stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.78 and $1.70. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, November 10, 2025, and so far it has risen 63.82%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.12 and $1.99. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Connect Biopharma Holdings Ltd American finds support just below today's level at $2.12. If this is broken, then the next support from accumulated volume will be at $1.99 and $1.98.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.509 between high and low, or 24.84%. For the last week, the stock has had daily average volatility of 17.20%.

The Connect Biopharma Holdings Ltd American stock is extremely overbought on RSI14 (82). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $2.41 (-3.36%) (This stock has high daily movements and this gives high risk. The RSI14 is 82 and this increases the risk substantially. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (CNTB) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $2.37, and during the day (based on 14 day Average True Range), to move between $2.40 and $2.58, which gives a possible trading interval of +/-$0.189 (+/-7.88%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 7.88% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.12, some $0.370 (14.86%) from the current price of $2.49, our system finds the risk reward attractive.

Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?

Connect Biopharma Holdings Ltd American holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.37 ( 4.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CNTB Performance

Trading levels for CNTB

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.88 15.51%
R2 2.68 7.70%
R1 2.56 2.87%
Price 2.49
S1 2.17 -12.76%
S2 2.05 -17.59%
S3 1.86 -25.40%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 2.49
S1 2.12 -14.86%
S2 1.99 -20.08%
S3 1.98 -20.48%

FAQ

What is the symbol for Connect Biopharma Holdings Limited American Depositary Shares Stock and on which exchange is it traded?
The symbol for Connect Biopharma Holdings Limited American Depositary Shares is CNTB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Ltd American holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

How to buy Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Limited American Depositary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.

What's the current price of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the end of day on the Nov 17, 2025, the price of an Connect Biopharma Holdings Limited American Depositary Shares (CNTB) share was $2.49.

What is the 52-week high and low for Connect Biopharma Holdings Limited American Depositary Shares Stock?
The 52-week high for Connect Biopharma Holdings Limited American Depositary Shares Stock is $2.86 and the 52-week low is $0.510.

What is the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the Nov 17, 2025, the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares is 139.188M.
Click to get the best stock tips daily for free!
ABOUT CONNECT BIOPHARMA HOLDINGS LIMITED AMERICAN DEPOSITARY SHARES
Connect Biopharma Holdings American Depositary Shares
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosin...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE